Leadership
Executive Vice President and Chief Marketing Officer
Amy Summy has served as Executive Vice President and Chief Marketing Officer since March 2020.
EVP and Chief Human Resources Officer
Anita Graham has served as Executive Vice President and Chief Human Resources Officer since 2023.
Chief Medical and Scientific Officer: EVP and President, Early Development Research Laboratories
Brian Caveney, M.D. has served in his combined roles at Labcorp since 2023.
Executive Vice President and Chief Financial Officer
Julia Wang has served as Executive Vice President and Chief Financial Officer of Labcorp since December 2024.
Executive Vice President and Special Advisor to the CEO
In November 2024, Glenn Eisenberg announced his planned retirement from Labcorp, effective April 30, 2025. Glenn served as Executive Vice President and Chief Financial Officer (CFO) since 2014. In December 2024, Glenn assumed the role as Special Advisor to the CEO to ensure a seamless transition of his current role and assist with strategic initiatives underway within the company.
EVP, Chief Information and Technology Officer
Bola Oyegunwa, Ph.D., has served as Labcorp’s Executive Vice President and Chief Information and Technology Officer since November 2024.
EVP and President, Diagnostics and Chief Operations Officer
Mark Schroeder has served as Labcorp’s Executive Vice President and President, Diagnostics and Chief Operations Officer since 2023.
EVP and President, Central Laboratories and International
Megan Bailey has served as Labcorp’s Executive Vice President and President, Central Laboratory Services and International since 2024.
EVP and Chief Legal Officer and Corporate Secretary
Sandy van der Vaart has served as Executive Vice President, Chief Legal Officer and Corporate Secretary of Labcorp since February 2020.
Director
Kerrii B. Anderson has served as a director of the Company since May 17, 2006.
Director, Chair of the Audit Committee
Jeffrey A. Davis has served as a director of the Company since December 1, 2019, and Chairman of the Audit Committee since June 2023.
Director
D. Gary Gilliland has served as a director of the Company since April 1, 2014.
Director
Kirsten M. Kliphouse has served as a director of the Company since October 12, 2022.
Lead Independent Director, Chair of the Nominating and Corporate Governance
Garheng Kong has served as a director of the Company since December 1, 2013 and Lead Independent Director since June 2023. Dr. Kong also serves as the Chair of the Nominating and Corporate Governance Committee for the Company.
Director
Peter M. Neupert has served as a director of the Company since January 1, 2013 and previously served as the Board’s lead independent director from July 2019 until June 2023.
Director, Chairperson of the Compensation and Human Capital Committee
Richelle Parham has served as a director of the Company since February 8, 2016 and Chairperson of the Compensation and Human Capital Committee since June 2023.
Director, Chair of the Quality and Compliance Committee
Paul B. Rothman has served as a director of the Company since June 6, 2023 and as Chairman of the Quality and Compliance Committee since June 2024.
Director
Kathryn E. Wengel has served as a director of the Company since March 25, 2021.
